Advertisement
Advertisement
BBNX
Beta Bionics, Inc. Common Stock
14.78
USDSponsored
-0.71
-4.58%
Nov 06, 11:56 UTC -5
Open
Beta Bionics, Inc. Common Stock (BBNX) Earnings
BBNX Earnings Reports
Positive Surprise Ratio
BBNX beat 6 of 8 last estimates.
75%
Next Report
Date of Next Report
Feb 15, 2027
Estimate for Q4 26 (Revenue/ EPS)
$31.85M
/-$0.49
Implied change from Q3 26 (Revenue/ EPS)
-10.30%
/-5.77%
Implied change from Q4 25 (Revenue/ EPS)
-0.85%
/+75.00%
Beta Bionics, Inc. Common Stock earnings per share and revenue
On Oct 27, 2026, BBNX reported earnings of -0.52 USD per share (EPS) for Q3 26, beating the estimate of -0.53 USD, resulting in a 2.73% surprise. Revenue reached 35.51 million, compared to an expected 35.42 million, with a 0.25% difference. The market reacted with a -16.55% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of -0.49 USD, with revenue projected to reach 31.85 million USD, implying an decrease of -5.77% EPS, and decrease of -10.30% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Tandem Diabetes Care, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.24
Actual
-$0.10
Surprise
+59.55%
Artivion, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.06
Actual
$0.08
Surprise
+228.00%
Mobia Medical, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.47
Actual
-$0.52
Surprise
-9.04%
Treace Medical Concepts, Inc. Common Stock
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$0.25
Actual
-$0.19
Surprise
+26.67%
Inogen Inc
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.56
Surprise
-285.41%
Envoy Medical, Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.68
Actual
-$0.50
Surprise
+26.47%
Mettler-Toledo International
Report Date
Nov 05, 2026 For Q3 26
Estimate
$12.21
Actual
$12.57
Surprise
+2.90%
Teleflex Incorporated
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.92
Actual
$2.63
Surprise
+36.82%
Pulse Biosciences, Inc Common Stock (DE)
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.37
Actual
-$0.32
Surprise
+14.05%
TransMedics Group, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.29
Actual
$0.51
Surprise
+71.31%
FAQ
What were Beta Bionics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Beta Bionics, Inc. Common Stock reported EPS of -$0.52, beating estimates by 2.73%, and revenue of $35.51M, 0.25% above expectations.
How did the market react to Beta Bionics, Inc. Common Stock's Q3 2026 earnings?
The stock price moved down -16.55%, changed from $21.39 before the earnings release to $17.85 the day after.
When is Beta Bionics, Inc. Common Stock expected to report next?
The next earning report is scheduled for Feb 15, 2027.
What are the forecasts for Beta Bionics, Inc. Common Stock's next earnings report?
Based on --
analysts, Beta Bionics, Inc. Common Stock is expected to report EPS of -$0.49 and revenue of $31.85M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.